CC vs PSA · P/E 72, rev $1.36B vs rev $4.82B
Chemours Co (CC) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
PSA (PSA) common stock.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CC currently screens at market cap $1.94B and trailing P/E 71.8. PSA currently screens at market cap $0.
Not investment advice. Open the CC and PSA stock pages for the full models.
Not investment advice.